中国银河证券股份有限公司 关于汕头市超声仪器研究所股份有限公司 本次上市流通的限售股属于公司首次公开发行网下配售限售股，股份数量 为3,577,474股，占公司总股本比例为0.84%，限售期为自公司首次公开发行并上 市之日起6个月，该部分限售股将于2025年7月22日锁定期届满并上市流通。 公司上市后至本核查意见出具日，公司未发生过因股份增发、回购注销及 派发过股票股利或用资本公积金转增股本等导致公司股本数量变动的情形。 二、申请解除股份限售股东履行承诺情况 1 根据公司《首次公开发行股票并在创业板上市之上市公告书》："网下发 行部分采用比例限售方式，网下投资者应当承诺其获配股票数量的10%（向上 取整计算）限售期限为自发行人首次公开发行并上市之日起6个月。即每个配售 对象获配的股票中，90%的股份无限售期，自本次发行股票在深交所上市交易 之日起即可流通；10%的股份限售期为6个月，限售期自本次发行股票在深交所 上市交易之日起开始计算。" 首次公开发行网下配售限售股份上市流通的核查意见 中国银河证券股份有限公司（以下简称"银河证券"、"保荐人"）作为 汕头市超声仪器研究所股份有限公司（以下简称"超研股份"、" ...

Core Viewpoint - Chao Yan Co., Ltd. has seen its stock price rise to 26.63 yuan, with a rolling PE ratio of 72.07, marking a new low in 63 days, and a total market capitalization of 11.406 billion yuan [1] Company Summary - Chao Yan Co., Ltd. specializes in the research, production, and sales of medical imaging equipment and industrial non-destructive testing equipment, with key products including industrial ultrasound, medical ultrasound, X-ray, and accessories [1] - The company has established a strong market presence and stable customer base, with its industrial ultrasound non-destructive testing products recognized as a Guangdong Province brand product [1] - In 2022, the company received a second-class National Defense Technology Invention Award from the Ministry of Industry and Information Technology for its project on "New Technology for High-Precision Non-Destructive Testing of Complex Large Components and Its Major Applications" [1] - For Q1 2025, the company reported revenue of 98.4324 million yuan, a year-on-year increase of 28.69%, and a net profit of 39.322 million yuan, up 47.70%, with a gross profit margin of 73.83% [1] Industry Summary - The average PE ratio for the medical device industry is 51.42, with a median of 37.44, positioning Chao Yan Co., Ltd. at 96th place in the industry ranking [1] - The static PE ratio for Chao Yan Co., Ltd. is 78.35, and the price-to-book ratio is 8.82 [2] - The total market capitalization of the medical device industry is 106.60 billion yuan [2]

Core Viewpoint - Chao Yan Co., Ltd. has a closing price of 24.78 yuan, down 1.82%, with a rolling PE ratio of 67.06 times and a total market value of 10.614 billion yuan, indicating a higher valuation compared to the industry average [1] Company Summary - Chao Yan Co., Ltd. specializes in the research, production, and sales of medical imaging equipment and industrial non-destructive testing equipment, with key products including industrial ultrasound, medical ultrasound, X-ray, and accessories [1] - The company has established a strong market presence and customer base, with its industrial ultrasound non-destructive testing products recognized as a Guangdong Province brand product [1] - In 2022, the company received the second prize of the National Defense Technology Invention Award from the Ministry of Industry and Information Technology for its project on "New Technology for High-Precision Non-Destructive Testing of Complex Large Components and Its Major Applications" [1] Financial Performance - For the first quarter of 2025, the company reported operating revenue of 98.4324 million yuan, a year-on-year increase of 28.69%, and a net profit of 39.322 million yuan, a year-on-year increase of 47.70%, with a gross profit margin of 73.83% [1] Industry Summary - The average PE ratio for the medical device industry is 51.29 times, with a median of 37.02 times, positioning Chao Yan Co., Ltd. at the 96th rank within the industry [1][2] - The industry average market value is 10.675 billion yuan, while the median market value is 5.063 billion yuan [2]

Overview - Non-destructive testing (NDT) technology is crucial in various sectors of China's economy, ensuring and improving product quality across industries from aerospace to everyday consumer goods [1][13] - The NDT equipment market in China is projected to reach a scale of 6.363 billion yuan in 2024, with a year-on-year growth of 3.87% [1][13] - The demand for advanced NDT technology is increasing as traditional methods are gradually replaced, leading to higher investments in advanced NDT equipment by enterprises [1][13] Market Policies - China has implemented several regulations and standards to enhance product quality and safety, creating a favorable policy environment for the NDT equipment industry [6][8] - Key policies include the "Action Plan for the Development of Intelligent Testing Equipment Industry (2023-2025)" and various guidelines aimed at promoting high-quality development in manufacturing and resource utilization [6][8] Industry Chain - The upstream of the NDT equipment industry includes suppliers of electronic components, metals, optical materials, and sensors, which directly impact the quality and scale of NDT equipment production [9] - The midstream involves the design, research, and production of NDT equipment, while the downstream consists of inspection and testing institutions that utilize these technologies [9] Development Status - The NDT market in China has seen rapid growth, with the industry becoming a key player in ensuring product quality across various sectors [1][13] - The number of qualified inspection and testing institutions reached 53,057 in 2024, generating revenues of 487.597 billion yuan, indicating a robust growth in the downstream market [11] Competitive Landscape - The NDT equipment industry is characterized by high technical barriers and a focus on technological competition, with few major players dominating the market [15][16] - Domestic companies like Chaoyan Co., Duopule Co., and Ultrasonic Electronics are gradually increasing their market share and closing the gap with international competitors [16][19][21] Future Trends - The future of NDT equipment will see increased adoption of digital technologies for data collection, storage, and transmission, enhancing decision-making in maintenance and quality control [23] - Collaboration among upstream and downstream players in the industry will be crucial for technological innovation and market expansion, improving overall competitiveness [23]

Core Viewpoint - The ultrasonic non-destructive testing (NDT) industry in China has developed rapidly, covering various industrial sectors, with a projected market size of 5.772 billion yuan in 2024, reflecting a year-on-year growth of 6.81% [1][17]. Overview - Non-destructive testing refers to methods that assess the properties and integrity of materials without causing damage, utilizing physical or chemical techniques to detect internal and surface defects [1]. - The main non-destructive testing methods include ultrasonic testing (UT), radiographic testing (RT), magnetic particle testing (MT), penetrant testing (PT), and eddy current testing (ET) [3]. Market Policy - Recent policies in China emphasize product quality and safety, mandating non-destructive testing across various industries to ensure compliance with standards [8][10]. - A series of regulations and action plans have been introduced to promote high-quality development in manufacturing and enhance the capabilities of inspection and testing services [8][10]. Industry Chain - The ultrasonic NDT industry comprises equipment manufacturers and service providers, with upstream suppliers including raw materials and components, and downstream markets spanning various sectors such as special equipment, rail transportation, and aerospace [11][13]. Market Demand - The special equipment sector represents the largest demand for non-destructive testing, accounting for approximately 30% of the market, followed by rail transportation at around 25% [13]. - The growth in infrastructure and manufacturing automation in the Asia-Pacific region, particularly in China, India, Japan, and South Korea, is driving market expansion [15]. Competitive Landscape - The ultrasonic NDT equipment market has high entry barriers, resulting in fewer participants and relatively mild competition, with key players including Shantou Ultrasonic Instrument Research Institute and Guangzhou Duopule Electronic Technology [19][22]. - The service market is more fragmented, with numerous small players, while larger institutions like China National Inspection Testing Group and Huace Testing hold significant market recognition [19][23]. Development Trends - The industry is expected to see increased demand from advanced manufacturing sectors such as electric vehicles and electronics, with ultrasonic testing technology expanding into non-metal and composite materials [26]. - There is a trend towards domestic substitution of high-end ultrasonic NDT equipment, driven by advancements in local research and development and government policies promoting self-sufficiency [26].

证券代码：301602 证券简称：超研股份 公告编号：2025-031 一、本次增资事项概述 汕头市超声仪器研究所股份有限公司（以下简称"公司"）于2025 年4月27日召开第二届董事会第八次会议，审议通过了《关于向子公 司增资的议案》。根据公司的发展战略和全资子公司深圳市汕超科技 有限公司（以下简称"深圳汕超"）的经营管理需要，公司董事会同 意公司以自有资金人民币50万元对深圳汕超进行增资。本次增资完成 后，深圳汕超的注册资本由人民币50万元增加至人民币100万元，仍 为公司全资子公司。 关于向子公司增资进展暨完成工商变更登记的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整， 没有虚假记载、误导性陈述或重大遗漏。 具体内容详见公司在巨潮资讯网（www.cninfo.com.cn）披露的 《关于向子公司增资的公告》（公告编号：2025-018）。 二、进展情况 近日，深圳汕超已完成相关工商变更登记手续并取得了由深圳市 市场监督管理局核准换发的《营业执照》。变更后的相关工商登记信 息如下： 1、公司名称：深圳市汕超科技有限公司 2、成立日期：2015年10月26日 汕头市超声仪器研究所股份有限公 ...

证券代码：301602 证券简称：超研股份 公告编号：2025-030 汕头市超声仪器研究所股份有限公司 2024 年度权益分派实施公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整， 没有虚假记载、误导性陈述或重大遗漏。 汕头市超声仪器研究所股份有限公司（以下简称"公司"）2024 年度权益分派方案已获 2025 年 5 月 20 日召开的 2024 年度股东会审 议通过，现将权益分派事宜公告如下： 一、股东会审议通过利润分配方案等情况 1、公司2024 年度股东会审议通过的2024年度利润分配方案为： 本公司拟以本次利润分配预案未来实施时股权登记日的公司总股本 为基数，拟向全体股东每 10 股派发人民币 1.02 元现金（含税），不 送红股，不进行资本公积金转增股本。截至目前公司总股本 428,329,638 股，以此计算合计拟派发现金分红 43,689,623.08 元（含 税），占 2024 年度合并报表归属于上市公司股东的净利润的 30.01%。 本次利润分配后尚未分配的利润结转以后年度分配。 公司权益分派具体实施前如因股份回购、股权激励行权、可转债 转股、再融资新增股份等原因发生股本变 ...

Group 1 - The core viewpoint of the news is that Chao Yan Co., Ltd. has a high rolling price-to-earnings (PE) ratio of 70.66, significantly above the industry average of 50.64, indicating a premium valuation in the medical device sector [1][2] - As of June 9, the company's stock closed at 26.11 yuan, with a market capitalization of 11.184 billion yuan, reflecting a 1.28% increase [1] - The company has experienced a net outflow of main funds amounting to 245.27 million yuan on June 9, with a total outflow of 2,328.49 million yuan over the past five days [1] Group 2 - Chao Yan Co., Ltd. specializes in the research, production, and sales of medical imaging equipment and industrial non-destructive testing equipment, with key products including industrial ultrasound, medical ultrasound, and X-ray equipment [1] - The company has established a strong market presence and customer base, with its industrial ultrasound non-destructive testing products recognized as a Guangdong Province brand product [1] - In 2022, the company received a second-class award for national defense technology invention from the Ministry of Industry and Information Technology for its project on "New Technology for High-Precision Non-Destructive Testing of Complex Large Components and Its Major Applications" [1] Group 3 - The latest financial results for the first quarter of 2025 show that the company achieved an operating income of 98.4324 million yuan, representing a year-on-year increase of 28.69%, and a net profit of 39.3220 million yuan, up 47.70% year-on-year, with a gross profit margin of 73.83% [1]

6月3日，超研股份今日收盘26.62元，上涨3.74%，滚动市盈率PE（当前股价与前四季度每股收益总和的 比值）达到72.04倍，创39天以来新低，总市值114.02亿元。 从行业市盈率排名来看，公司所处的医疗器械行业市盈率平均50.80倍，行业中值36.71倍，超研股份排 名第99位。 截至2025年一季报，共有15家机构持仓超研股份，其中基金13家、其他1家、QFII1家，合计持股数 68.15万股，持股市值0.18亿元。 汕头市超声仪器研究所股份有限公司的主营业务是医学影像设备、工业无损检测设备的研发、生产和销 售。公司的主要产品是工业超声、医用超声、X射线、配附件。经过多年积累，公司已拥有较高的市场 知名度和稳定的客户基础，工业超声无损检测产品被评为广东省名牌产品；2022年，公司凭借"复杂超 大构件高精密无损检测新技术及其重大应用"项目获得国家工业和信息化部颁发的国防技术发明奖二等 奖。 序号股票简称PE(TTM)PE(静)市净率总市值(元)99超研股份72.0478.328.81114.02亿行业平均 50.8049.074.67108.36亿行业中值36.7136.842.4850.19亿1天益 ...

证券代码：301602 证券简称：超研股份 汕头市超声仪器研究所股份有限公司 投资者关系活动记录表 编号：2025-002 答：您好，股票价格是多种因素综合影响的结果，公司一直以 提升经济效益为目标，重视公司市值成长，以期回报广大投资 者的信任。感谢您的关注! 4、请问公司预计未来业绩增长点会出在哪个方向？ 答：您好，公司未来的盈利增长将主要来源于将超声、射线、 人工智能技术与用户需求相结合不断推出的创新型产品。如公 司在国内率先提出了医用超声扫描标准化和诊断智能化的解 决方案，并已经应用于智能乳腺全容积超声诊断系统等产品， 为超声产品在专科诊疗领域推广应用带来了广阔的增长空间； 将可免防护便携式 DR 与掌上超声相结合，为应急救援领域等 带来全新的多模态影像诊断工具。在无损检测领域，2024 年 推出了爬壁机器人检测系统，能够代替人工在特殊环境中进行 超声检测和视觉检测，降低作业风险也提高了检测效率和检测 质量。以上这些都是未来公司业绩新的增长点。感谢您的关注！ 5、董事长好！公司刚上市半年，7 月份就解禁 350 多万股会 对目前的股价有重大影响吗？ 答：您好，股票价格受宏观环境、行业政策、投资者偏好等多 ...